USD 0.01
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 58.11 Thousand USD | -7.85% |
2022 | 63.06 Thousand USD | 5.16% |
2021 | 59.96 Thousand USD | 9.94% |
2020 | 54.54 Thousand USD | -14.07% |
2019 | 63.47 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 10.13 Thousand USD | -9.69% |
2024 Q2 | 19.99 Thousand USD | 97.37% |
2023 Q4 | 11.21 Thousand USD | -25.24% |
2023 FY | 58.11 Thousand USD | -7.85% |
2023 Q3 | 15 Thousand USD | -27.15% |
2023 Q2 | 20.6 Thousand USD | 82.54% |
2023 Q1 | 11.28 Thousand USD | 13.6% |
2022 Q3 | 13.06 Thousand USD | 0.0% |
2022 FY | 63.06 Thousand USD | 5.16% |
2022 Q4 | 9934.00 USD | -23.94% |
2021 FY | 59.96 Thousand USD | 9.94% |
2020 FY | 54.54 Thousand USD | -14.07% |
2019 FY | 63.47 Thousand USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Bio Medica Corporation | 1.04 Million USD | 94.46% |
Arrayit Corporation | 6.19 Million USD | 99.062% |
Atlantic International Corp. | 5.57 Million USD | 98.958% |
Biocept, Inc. | 29.4 Million USD | 99.802% |
Bioqual, Inc. | 7.44 Million USD | 99.22% |
CardioGenics Holdings Inc | 772.14 Thousand USD | 92.474% |
DermTech, Inc. | 104.01 Million USD | 99.944% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 99.965% |
HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 99.743% |
iMD Companies, Inc. | 151.8 Thousand USD | 61.72% |
IDenta Corp. | 662.97 Thousand USD | 91.235% |
Interpace Biosciences, Inc. | 20.23 Million USD | 99.713% |
Integrative Health Technologies, Inc. | 38.88 Thousand USD | -49.461% |
InVitro International | 661.32 Thousand USD | 91.213% |
Lumos Diagnostics Holdings Limited | 7.09 Million USD | 99.181% |
Medical Imaging Corp. | 1.91 Million USD | 96.961% |
NovelStem International Corp. | 3.53 Million USD | 98.357% |
Optigenex Inc. | 1.28 Million USD | 95.488% |
PharmChem, Inc. | 2.93 Million USD | 98.017% |
Proteome Sciences plc | 3.26 Million USD | 98.222% |
Response Genetics, Inc | 25.31 Million USD | 99.77% |
Rennova Health, Inc. | 7.67 Million USD | 99.243% |
RushNet, Inc. | 1.78 Million USD | 96.752% |
ScreenPro Security Inc. | 3.23 Million USD | 98.206% |
Stella Diagnostics Inc. | 11.42 Million USD | 99.491% |
StageZero Life Sciences Ltd. | 7.34 Million USD | 99.209% |
Todos Medical Ltd. | 14.05 Million USD | 99.587% |